Therapy With m-TOR Inhibitors Decreases the Response to the Pandemic Influenza A H1N1 Vaccine in Solid Organ Transplant Recipients
Open Access
- 10 August 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (10), 2205-2213
- https://doi.org/10.1111/j.1600-6143.2011.03692.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and MetabolismImmunity, 2010
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort studyThe Lancet Infectious Diseases, 2010
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- mTOR regulates memory CD8 T-cell differentiationNature, 2009
- Enhancing CD8 T-cell memory by modulating fatty acid metabolismNature, 2009
- Hypogammaglobulinemia and infection risk in solid organ transplant recipientsCurrent Opinion in Organ Transplantation, 2008
- TOR Signaling in Growth and MetabolismCell, 2006